Vaxart, Inc. SEC filings VXRT

Vaxart, Inc. has 1,002 filings in SEC EDGAR's recent list, going back to May 18, 2011. Its latest annual report, Form ARS, was filed on Jun 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Jun 1, 2026 Dec 31, 2025
10-K/A Amended annual report Apr 30, 2026 Dec 31, 2025
10-K Annual report Mar 13, 2026 Dec 31, 2025
ARS Annual report to shareholders Apr 10, 2025 Dec 31, 2024
10-K Annual report Mar 20, 2025 Dec 31, 2024
ARS Annual report to shareholders Apr 29, 2024 Dec 31, 2023
10-K Annual report Mar 14, 2024 Dec 31, 2023
10-K Annual report Mar 15, 2023 Dec 31, 2022
10-K Annual report Feb 24, 2022 Dec 31, 2021
10-K Annual report Feb 25, 2021 Dec 31, 2020
10-K Annual report Mar 19, 2020 Dec 31, 2019
10-K Annual report Feb 6, 2019 Dec 31, 2018
10-K/A Amended annual report Oct 20, 2017 Jun 30, 2017
10-K Annual report Sep 1, 2017 Jun 30, 2017
10-K Annual report Sep 13, 2016 Jun 30, 2016
ARS Annual report to shareholders Oct 14, 2015 Jun 30, 2015
10-K Annual report Sep 11, 2015 Jun 30, 2015
10-K Annual report Sep 30, 2014 Jun 30, 2014
10-K Annual report Sep 27, 2013 Jun 30, 2013
10-K/A Amended annual report Apr 30, 2012 Dec 31, 2011
10-K Annual report Mar 14, 2012 Dec 31, 2011

Showing 21 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
VXRT (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
South San Francisco, CA
SEC filer status
Accelerated filer, Smaller reporting company
SEC CIK
72444
Former names
Aviragen Therapeutics, Inc. (until Feb 15, 2018); Biota Pharmaceuticals, Inc. (until Apr 13, 2016); NABI BIOPHARMACEUTICALS (until Nov 8, 2012); NABI BIOPHARMACEUTICALS (until Jun 29, 2010); NABI /DE/ (until Feb 14, 2002)

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.